New digital platform treats insomnia and anxiety in seniors
Cognitive behavioral therapies for insomnia (CBT-I) are increasingly being delivered online in order to improve accessibility. However, although…
New peptide triggers domino effect to suppress bladder cancer
Background Recently, a research team led by Professors Dahong Zhang and Qi Zhang from the Urology Department and…
Combination therapy improves response rates for chronic hepatitis B patients
Background and aims The optimal management strategy for adults with immune-tolerant (IT) chronic hepatitis B infection remains undefined.…
Evaluating stroke-prevention strategies in patients with atrial fibrillation by age
The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a subgroup analysis of the CHAMPION-AF…
Uneven grey matter loss serves as a powerful new biomarker for early neurodegeneration
Universitat Oberta de Catalunya Alzheimer’s disease begins to weave a web in the brain and remodel neuronal tissue…
Obesity drugs and surgery linked to greater fat-free mass loss
A new systematic review and meta-analysis of studies presented at this year’s European Congress on Obesity in Istanbul,…
Eating eggs regularly reduces Alzheimer’s disease risk
Researchers tracked nearly 40,000 older adults for 15 years and found that people who consumed eggs moderately developed…
A new tool that predicts obesity-related disease risk beyond BMI
A data-driven tool built from nearly 200,000 individuals reveals who is most likely to develop serious obesity-related diseases,…
Twice-yearly blood pressure treatment could reshape hypertension care, but doctors warn against a “fire-and-forget” approach
A new Perspective argues that long-acting siRNA therapies could ease the daily burden of hypertension treatment, but only…
Targeting glutamine metabolism enhances CAR-macrophage cancer therapy
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function. Specifically,…
ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery
ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the CYTOQUBE high-throughput 3D…
A new model to break the cycle of chronic nightmares in children
A novel framework reveals why nightmares persist in children, and how building confidence and coping skills could help…